Jan 1, 2020
In Part II of this episode, we continue to take a look back at 2019 with Dr. Andrew Cutler, as we reflect on the most FDA approvals, exciting research findings and all the important updates in psychopharmacology that could impact your practice.
Dr. Andrew Cutler is Chief Medical Officer (CMO) at the Neuroscience Education Institute (NEI). He has deeply rooted knowledge in clinical practice, academic experience, and emerging science in psychiatry through clinical trials. He is Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and previously served as Courtesy Assistant Professor of Psychiatry at University of Florida. He has been the principal investigator on more than 400 psychiatric and medical clinical trials.